Companies / HilleVax, Inc.
HilleVax, Inc.
HLVXCIK 1888012
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 3, 2022 | Frazier Life Sciences Public Fund, L.P. 10% owner | Other Derivative conversion | Common Stock | $37.21M | +2.7M +67.82% | 6,770,631 | low |
| May 3, 2022 | Frazier Life Sciences Public Fund, L.P. 10% owner | Buy Open-market buy | Common Stock | $30.00M | +1.8M +26.06% | 8,535,337 | high |
| Sep 17, 2025 | Frazier Life Sciences Public Fund, L.P. 10% owner | Other Shares tendered | Common Stock | $16.64M | -8.5M -100.00% | 0 | low |
| Sep 17, 2025 | Takeda Pharmaceutical Co Ltd 10% owner | Other Shares tendered | Common Stock | $13.11M | -6.7M -100.00% | 0 | low |
| Feb 8, 2024 | Hershberg Robert Executive | Sell Open-market sale | Common Stock | $173.2K | -12K -1.20% | 953,831 | medium |
| Mar 20, 2024 | Kohli Aditya Executive | Sell Open-market sale | Common Stock | $164.2K | -6K -0.74% | 807,776 | medium |
| Jun 21, 2023 | Borkowski Astrid Executive | Other Sold to issuer | Common Stock | $161.1K | -10K -4.54% | 210,193 | low |
| Dec 15, 2023 | Borkowski Astrid Executive | Sell Open-market sale | Common Stock | $155.0K | -10K -5.71% | 165,193 | medium |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| HLVX | common | 43157M102 |